These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 34845765

  • 21. Red cell alloimmunisation following intrauterine transfusion and the feasibility of providing extended phenotype-matched red cell units.
    Doyle B, Quigley J, Lambert M, Crumlish J, Walsh C, Adshead S, Woolfson M, McParland P, Culliton M, Fitzgerald J.
    Transfus Med; 2014 Oct; 24(5):311-5. PubMed ID: 25229430
    [Abstract] [Full Text] [Related]

  • 22. Molecular blood typing augments serologic testing and allows for enhanced matching of red blood cells for transfusion in patients with sickle cell disease.
    Wilkinson K, Harris S, Gaur P, Haile A, Armour R, Teramura G, Delaney M.
    Transfusion; 2012 Feb; 52(2):381-8. PubMed ID: 21827505
    [Abstract] [Full Text] [Related]

  • 23. Clinical significance of RBC alloantibodies and autoantibodies in sickle cell patients who received transfusions.
    Aygun B, Padmanabhan S, Paley C, Chandrasekaran V.
    Transfusion; 2002 Jan; 42(1):37-43. PubMed ID: 11896310
    [Abstract] [Full Text] [Related]

  • 24. Frequencies of red blood cell major blood group antigens and phenotypes in the Chinese Han population from Mainland China.
    Yu Y, Ma C, Sun X, Guan X, Zhang X, Saldanha J, Chen L, Wang D.
    Int J Immunogenet; 2016 Aug; 43(4):226-35. PubMed ID: 27320061
    [Abstract] [Full Text] [Related]

  • 25. Red Blood Cell Antigen Genotyping for Sickle Cell Disease, Thalassemia, and Other Transfusion Complications.
    Fasano RM, Chou ST.
    Transfus Med Rev; 2016 Oct; 30(4):197-201. PubMed ID: 27345938
    [Abstract] [Full Text] [Related]

  • 26. Complete RH and Kell matching related to low alloimmunisation risk in sickle cell disease: prevalence and risk factors of alloimmunisation in a Spanish Tertiary Care National Reference Centre.
    Regalado-Artamendi I, Pérez-Corral AM, García-Morín M, Cela E, Beléndez C, Bardón-Cancho EJ, Pérez-Rus G, Pérez-Sánchez I, Pascual C, Monsalvo S, Falero C, Díez-Martín JL, Anguita J.
    Blood Transfus; 2021 Jul; 19(4):292-299. PubMed ID: 33085598
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Red blood cell alloimmunization and minor red blood cell antigen phenotypes in transfused Ghanaian patients with sickle cell disease.
    Boateng LA, Campbell AD, Davenport RD, Osei-Akoto A, Hugan S, Asamoah A, Schonewille H.
    Transfusion; 2019 Jun; 59(6):2016-2022. PubMed ID: 30758856
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. [Transfusion of patients with autoimmune hemolytic anemia].
    Ueda Y.
    Rinsho Ketsueki; 2018 Jun; 59(10):2354-2361. PubMed ID: 30305546
    [Abstract] [Full Text] [Related]

  • 32. Toward extended phenotype matching: a new operational paradigm for the transfusion service.
    Klapper E, Zhang Y, Figueroa P, Ness P, Stubbs J, Abumuhor I, Bailey J, Epperson L, Tauscher C, Enriquez E, Hashmi G, Seul M.
    Transfusion; 2010 Mar; 50(3):536-46. PubMed ID: 19929860
    [Abstract] [Full Text] [Related]

  • 33. Red blood cell alloimmunisation after platelet transfusion (excluding ABO blood group system).
    Moncharmont P.
    Transfus Clin Biol; 2020 Aug; 27(3):185-190. PubMed ID: 32544526
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. HLA polymorphisms and risk of red blood cell alloimmunisation in polytransfused patients with sickle cell anaemia.
    Rodrigues C, Sell AM, Guelsin GAS, Higa TT, Pagliarini E Silva S, Macedo LC, Sippert EÂ, de Alencar JB, Zanette Â, Acorsi CRL, Castilho L, Visentainer JEL.
    Transfus Med; 2017 Dec; 27(6):437-443. PubMed ID: 28881103
    [Abstract] [Full Text] [Related]

  • 36. RBC Transfusion Strategy in Oncological Patients with Chronic RBC Transfusion Therapy.
    Fang W, Pang C, Zhang F, Zhang H, Peng T, Liu M, Yu J, Zhao R, Cai J, Chen S, Li X.
    Clin Lab; 2023 Aug 01; 69(8):. PubMed ID: 37560861
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Clinical outcome of transfusions with extended red blood cell matching in β-thalassemia patients: A single-center experience.
    Belsito A, Costa D, Signoriello S, Fiorito C, Tartaglione I, Casale M, Perrotta S, Magnussen K, Napoli C.
    Transfus Apher Sci; 2019 Feb 01; 58(1):65-71. PubMed ID: 30591410
    [Abstract] [Full Text] [Related]

  • 39. Selection of GP. Mur antigen-negative RBC for blood recipients with anti-'Mia ' records decreases transfusion reaction rates in Taiwan.
    Yang CA, Lin JA, Chang CW, Wu KH, Yeh SP, Ho CM, Chang JG.
    Transfus Med; 2016 Oct 01; 26(5):349-354. PubMed ID: 27634577
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.